Monograph Details

Cardiovascular System > Hyperlipoproteinemias
ZETIA
Manufacturer
Merck/Schering-Plough
Legal Classification
Rx
Pharmacological Class
Cholesterol absorption inhibitor.
Generic Name
Ezetimibe 10mg; tabs.
Indications
Adjunct to diet, alone or in combination with an HMG-CoA reductase inhibitor (statin), in primary hypercholesterolemia (heterozygous familial and non-familial) to reduce elevated total-C, LDL-C, and Apo B. Adjunct to diet and in combination with fenofibrate to reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in mixed hyperlipidemia. Adjunct to other lipid-lowering treatments, or if these treatments are unavailable, with atorvastatin or simvastatin to reduce elevated total-C and LDL-C in homozygous familial hypercholesterolemia. Adjunct to diet in homozygous familial sitosterolemia to reduce elevated sitosterol and campesterol.
Children
<10 years: not recommended.
Adults
≥10 years: 10mg once daily.
Contraindications
The use of ezetimibe with a statin is contraindicated in active liver disease or unexplained persistent elevations in serum transaminases. Statins are contraindicated in pregnancy and nursing.
Precautions
Moderate to severe hepatic insufficiency: not recommended. If given with a statin: monitor liver function initially and then as recommended for the statin. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Interactions
Concomitant fibrates (except fenofibrate): not recommended. Potentiates cyclosporine. Potentiated by fenofibrate, gemfibrozil, cyclosporine. Monitor warfarin, cyclosporine. Separate dosing of bile acid sequestrants (give ≥2 hours before or ≥4 hours after).
Adverse Reactions
Back pain, arthralgia, diarrhea, abdominal pain, fatigue, cough; rare: myopathy/rhabdomyolysis; w. statin: increased serum transaminases.
Extra Text
Note: For more information on statins, see their entries.
How Supplied
Tabs—30, 90, 500
Additional Resources
Related Prescribing Note